Related Experiment Video
Updated: Apr 1, 2026

06:16
Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
Published on: June 6, 2020
4.7K
Translating research knowledge in dementia care organisations.
Hussain Alyami1, Kathy Peri2, Jane Vanderpyl3
1Psychiatry Registrar, Auckland Regional Psychiatry Training Programme, Auckland, New Zealand.
Summary
Dementia care organizations have skilled staff but lack organizational support for research. Strategies are proposed to improve knowledge translation in dementia care.
Area of Science:
- Gerontology
- Healthcare Management
- Knowledge Translation
Background:
- Effective dementia care relies on integrating research findings into practice.
- Organisational capacity significantly influences the adoption of evidence-based practices in healthcare settings.
Purpose of the Study:
- To assess the capabilities of dementia care organizations in New Zealand to acquire, evaluate, adapt, and implement dementia research.
- To identify barriers and facilitators to research utilization within dementia care settings.
Main Methods:
- An online survey, adapted from the Canadian Health Services Research Foundation's 'Is research working for you?' tool, was distributed.
- Members of the New Zealand National Dementia Cooperative were invited to participate.
Main Results:
- 146 responses (32% participation rate) indicated that while staff possessed research skills, organizational support was limited.
- Key limitations included insufficient time, resources, and access to external support for research engagement and implementation.
- A gap exists between the workforce's research capabilities and the organizational infrastructure to support evidence-based practice.
Conclusions:
- The study highlights a need for enhanced organizational support to foster research uptake in dementia care.
- Proposed strategies aim to improve knowledge translation, bridging the gap between research evidence and clinical practice.
- Strengthening organizational capacity is crucial for advancing dementia care quality through research integration.
Related Concept Videos
Dementia
708
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
708
Documentation in Long-Term and Home Healthcare Setting
1.7K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.7K
Restorative Care
2.5K
Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
2.5K
Improving Translational Accuracy
3.8K
3.8K
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K

